Publication | Open Access

5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder

Luteal Phase IncreaseHormonal ContraceptiveEndocrine MechanismMedicineGynecologyPlasma Allopregnanolone LevelsMenopauseReproductive MedicineFemale Reproductive FunctionPublic HealthEndocrinologyPharmacologyOvarian Hormone5α-Reductase Inhibition PreventsWomen's HealthReproductive Endocrinology